{"id":30372,"date":"2025-01-21T15:45:00","date_gmt":"2025-01-21T14:45:00","guid":{"rendered":"https:\/\/ggba.swiss\/brainscape-medical-makes-strides-in-long-term-brain-monitoring\/"},"modified":"2025-02-05T10:30:56","modified_gmt":"2025-02-05T09:30:56","slug":"brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/","title":{"rendered":"BrainScape Medical r\u00e9alise des avanc\u00e9es majeures dans la surveillance c\u00e9r\u00e9brale \u00e0 long terme"},"content":{"rendered":"\n

Fond\u00e9e fin 2024, BrainScape Medical<\/a> a pour ambition de r\u00e9volutionner le diagnostic, le suivi et le traitement des troubles neurologiques. Gr\u00e2ce \u00e0 un accord de licence exclusif avec le Wyss Center for Bio and Neuro Engineering<\/a>, BrainScape a acquis la technologie Epios\u00ae (maintenant appel\u00e9e la plateforme Brainscape), un dispositif implantable de pointe d\u00e9velopp\u00e9 \u00e0 Gen\u00e8ve. Cette innovation permet de relever les d\u00e9fis li\u00e9s \u00e0 la saisie de donn\u00e9es continues et \u00e0 long terme sur l’activit\u00e9 c\u00e9r\u00e9brale, ce qui est essentiel pour g\u00e9rer des maladies complexes telles que l’\u00e9pilepsie et la d\u00e9mence, qui touchent des millions de personnes dans le monde.<\/p>\n\n\n\n

La plateforme Brainscape combine la surveillance et l’intervention th\u00e9rapeutique en un seul syst\u00e8me peu invasif. En fournissant des informations en temps r\u00e9el et en permettant le neurofeedback et la stimulation, la technologie vise \u00e0 am\u00e9liorer les r\u00e9sultats pour les patients tout en \u00e9tablissant une nouvelle norme en mati\u00e8re de soins personnalis\u00e9s.<\/p>\n\n\n\n

Le premier essai humain de la plateforme Brainscape a d\u00e9montr\u00e9 la s\u00e9curit\u00e9 et l’efficacit\u00e9 du dispositif. Men\u00e9e sur huit patients pendant neuf jours, l’\u00e9tude a permis d’enregistrer avec succ\u00e8s des signaux EEG \u00e0 long terme avec une couverture compl\u00e8te de la t\u00eate. Publi\u00e9s dans des revues m\u00e9dicales de premier plan, ces r\u00e9sultats font de la plateforme Brainscape une solution r\u00e9volutionnaire pour la d\u00e9tection de l’activit\u00e9 c\u00e9r\u00e9brale, ouvrant la voie \u00e0 des applications cliniques \u00e9largies et \u00e0 des interventions th\u00e9rapeutiques personnalis\u00e9es.<\/p>\n\n\n\n

Une avanc\u00e9e dans le domaine de la neurologie soutenu par l’\u00e9cosyst\u00e8me d’innovation de la Suisse occidentale<\/h4>\n\n\n\n

Dans le communiqu\u00e9 de presse de l’entreprise, le Dr Erwin B\u00f6ttinger, directeur du Wyss Center, a soulign\u00e9 le potentiel de cette collaboration : \u00bb Les progr\u00e8s r\u00e9alis\u00e9s par BrainScape Medical refl\u00e8tent notre engagement \u00e0 transposer la recherche innovante en solutions concr\u00e8tes qui am\u00e9liorent la vie des gens. \u00bb<\/p>\n\n\n\n

La plateforme Brainscape a re\u00e7u la d\u00e9signation \u00ab Breakthrough Device Designation \u00bb de la FDA am\u00e9ricaine pour son potentiel \u00e0 r\u00e9pondre \u00e0 des besoins non satisfaits dans la gestion de l’\u00e9pilepsie pharmacor\u00e9sistante et des \u00e9pisodes \u00e9pileptiques peu fr\u00e9quents. Cette reconnaissance permettra de rationaliser les processus r\u00e9glementaires et d’acc\u00e9l\u00e9rer l’acc\u00e8s des patients \u00e0 cette technologie sur le march\u00e9 am\u00e9ricain.<\/p>\n\n\n\n

Pour soutenir sa croissance, BrainScape Medical a nomm\u00e9 la Dr Laura Johnson au poste de CEO. Avec plus de 20 ans d’exp\u00e9rience dans le domaine de la technologie m\u00e9dicale, le Dr Johnson apporte sa vision pour faire progresser le march\u00e9 des neuroth\u00e9rapies. Elle a pour objectif de mener BrainScape \u00e0 travers un cycle de financement de s\u00e9rie A, de soutenir l’approbation de la FDA et d’explorer de nouvelles applications pour sa technologie.<\/p>\n\n\n\n

Soutenue dans son implantation par le GGBa<\/a> et l’Office Cantonal de l’\u00c9conomie et de l’Innovation (OCEI<\/a>), BrainScape Medical a son si\u00e8ge au Campus Biotech<\/a> \u00e0 Gen\u00e8ve, tirant parti du solide \u00e9cosyst\u00e8me d’innovation de la r\u00e9gion. Gr\u00e2ce \u00e0 la technologie de Brainscape et \u00e0 une feuille de route claire pour sa croissance, la soci\u00e9t\u00e9 est en passe de transformer le traitement des troubles neurologiques et d’am\u00e9liorer la qualit\u00e9 des soins pour des millions de personnes dans le monde.<\/p>\n","protected":false},"excerpt":{"rendered":"

La soci\u00e9t\u00e9 genevoise BrainScape Medical, r\u00e9cemment cr\u00e9\u00e9e et sp\u00e9cialis\u00e9e dans les technologies de neuromonitoring et de neurostimulation, a annonc\u00e9 plusieurs \u00e9tapes importantes, notamment une nouvelle direction, la d\u00e9signation Breakthrough Device de la FDA et les r\u00e9sultats prometteurs de ses premiers essais sur l’homme.<\/p>\n","protected":false},"author":6,"featured_media":30369,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1188,1154,1181,1163,1239],"class_list":["post-30372","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-healthcare-fr-2","tag-investment-fr-2","tag-medical-devices-fr","tag-medtech-fr-2","tag-neuroscience-fr-2"],"acf":[],"yoast_head":"\nBrainScape r\u00e9alise des avanc\u00e9es dans la surveillance c\u00e9r\u00e9brale<\/title>\n<meta name=\"description\" content=\"BrainScape a obtenu la d\u00e9signation Breakthrough Device du FDA et des r\u00e9sultats prometteurs de ses premiers essais sur l'homme.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BrainScape r\u00e9alise des avanc\u00e9es dans la surveillance c\u00e9r\u00e9brale\" \/>\n<meta property=\"og:description\" content=\"BrainScape a obtenu la d\u00e9signation Breakthrough Device du FDA et des r\u00e9sultats prometteurs de ses premiers essais sur l'homme.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-21T14:45:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-05T09:30:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"BrainScape Medical r\u00e9alise des avanc\u00e9es majeures dans la surveillance c\u00e9r\u00e9brale \u00e0 long terme\",\"datePublished\":\"2025-01-21T14:45:00+00:00\",\"dateModified\":\"2025-02-05T09:30:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/\"},\"wordCount\":582,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg\",\"keywords\":[\"Healthcare\",\"Investment\",\"Medical Devices\",\"Medtech\",\"Neuroscience\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/\",\"name\":\"BrainScape r\u00e9alise des avanc\u00e9es dans la surveillance c\u00e9r\u00e9brale\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg\",\"datePublished\":\"2025-01-21T14:45:00+00:00\",\"dateModified\":\"2025-02-05T09:30:56+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"BrainScape a obtenu la d\u00e9signation Breakthrough Device du FDA et des r\u00e9sultats prometteurs de ses premiers essais sur l'homme.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"La technologie de BrainScape Medical associe une surveillance c\u00e9r\u00e9brale de pointe \u00e0 des interventions th\u00e9rapeutiques, offrant ainsi un nouvel espoir de gestion des troubles neurologiques gr\u00e2ce \u00e0 des soins personnalis\u00e9s. | \u00a9 BrainScape Medical\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BrainScape Medical r\u00e9alise des avanc\u00e9es majeures dans la surveillance c\u00e9r\u00e9brale \u00e0 long terme\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BrainScape r\u00e9alise des avanc\u00e9es dans la surveillance c\u00e9r\u00e9brale","description":"BrainScape a obtenu la d\u00e9signation Breakthrough Device du FDA et des r\u00e9sultats prometteurs de ses premiers essais sur l'homme.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/","og_locale":"fr_FR","og_type":"article","og_title":"BrainScape r\u00e9alise des avanc\u00e9es dans la surveillance c\u00e9r\u00e9brale","og_description":"BrainScape a obtenu la d\u00e9signation Breakthrough Device du FDA et des r\u00e9sultats prometteurs de ses premiers essais sur l'homme.","og_url":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-01-21T14:45:00+00:00","article_modified_time":"2025-02-05T09:30:56+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"BrainScape Medical r\u00e9alise des avanc\u00e9es majeures dans la surveillance c\u00e9r\u00e9brale \u00e0 long terme","datePublished":"2025-01-21T14:45:00+00:00","dateModified":"2025-02-05T09:30:56+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/"},"wordCount":582,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg","keywords":["Healthcare","Investment","Medical Devices","Medtech","Neuroscience"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/","url":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/","name":"BrainScape r\u00e9alise des avanc\u00e9es dans la surveillance c\u00e9r\u00e9brale","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg","datePublished":"2025-01-21T14:45:00+00:00","dateModified":"2025-02-05T09:30:56+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"BrainScape a obtenu la d\u00e9signation Breakthrough Device du FDA et des r\u00e9sultats prometteurs de ses premiers essais sur l'homme.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/Brainscape-Medical-Geneva-1180x811-1.jpeg","width":1180,"height":811,"caption":"La technologie de BrainScape Medical associe une surveillance c\u00e9r\u00e9brale de pointe \u00e0 des interventions th\u00e9rapeutiques, offrant ainsi un nouvel espoir de gestion des troubles neurologiques gr\u00e2ce \u00e0 des soins personnalis\u00e9s. | \u00a9 BrainScape Medical"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/brainscape-medical-realise-des-avancees-majeures-dans-la-surveillance-cerebrale-a-long-terme\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"BrainScape Medical r\u00e9alise des avanc\u00e9es majeures dans la surveillance c\u00e9r\u00e9brale \u00e0 long terme"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30372","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=30372"}],"version-history":[{"count":4,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30372\/revisions"}],"predecessor-version":[{"id":30834,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30372\/revisions\/30834"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/30369"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=30372"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=30372"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=30372"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}